Abbott must face lawsuit over PediaSure growth claims

A federal judge ruled that Abbott Laboratories must defend against a proposed class-action lawsuit alleging it misled consumers about PediaSure's ability to increase height. The court found that marketing materials featuring giraffes and basketball players could lead buyers to believe the product was clinically proven to make children taller.

洞察:

Abbott Laboratories must defend against a proposed class-action lawsuit after a federal judge ruled that marketing for its PediaSure Grow & Gain drinks could mislead consumers about height growth. U.S. District Judge Paul Engelmayer ruled on Thursday that visual cues on labels and in commercials could support a consumer belief that the product is clinically proven to make children taller. The decision allows claims of deceptive marketing to proceed to trial for the Abbott Park, Illinois-based company.

Visual Marketing Under Judicial Scrutiny

IUX24

IUX24 提供深度財經、經濟與投資資訊,藉助 AI 發掘全球市場中最重要的信號。

IFZA Properties, Dubai Silicon Oasis, DSO-IFZA, Dubai, United Arab Emirates

Copyright IUX24 MEDIA - FZCO. 版權所有。

由 AI 驅動 • 精益求精

IUX24 是一個資訊與分析平台,提供新聞、市場數據、分析工具及 AI 驅動的功能,僅供資訊參考與教育用途。所提供的服務和資訊不構成投資建議、交易信號或經紀服務。投資涉及風險,用戶在作出投資決定前應審慎評估相關資訊。